dividend yield

Search documents
Why ConnectOne Bancorp (CNOB) is a Top Dividend Stock for Your Portfolio
ZACKS· 2025-04-30 16:50
Company Overview - ConnectOne Bancorp (CNOB) is based in Englewood Cliffs and operates in the Finance sector, with a year-to-date share price change of -0.74% [3] - The company currently pays a dividend of $0.18 per share, resulting in a dividend yield of 3.17%, which is higher than the Banks - Northeast industry's yield of 2.87% and the S&P 500's yield of 1.64% [3] Dividend Performance - The annualized dividend of $0.72 represents a 1.4% increase from the previous year [4] - Over the past 5 years, ConnectOne Bancorp has increased its dividend 4 times, achieving an average annual increase of 18.45% [4] - The current payout ratio is 38%, indicating that the company pays out 38% of its trailing 12-month earnings per share as dividends [4] Earnings Growth - The Zacks Consensus Estimate for 2025 projects earnings of $2.48 per share, reflecting a year-over-year earnings growth rate of 36.26% [5] Investment Considerations - Dividends are favored by investors as they enhance stock investing profits, reduce overall portfolio risk, and offer tax advantages [6] - While established firms are typically viewed as the best dividend options, high-growth businesses and tech start-ups rarely offer dividends [7] - CNOB is considered a compelling investment opportunity due to its strong dividend profile and current Zacks Rank of 3 (Hold) [7]
Why Acadia Realty Trust (AKR) is a Top Dividend Stock for Your Portfolio
ZACKS· 2025-04-30 16:50
Company Overview - Acadia Realty Trust (AKR) is a real estate investment trust headquartered in Rye, operating in the Finance sector [3] - The stock has experienced a price decline of 19.12% since the beginning of the year [3] Dividend Information - Acadia Realty Trust currently pays a dividend of $0.20 per share, resulting in a dividend yield of 4.09% [3] - The industry average yield for REIT and Equity Trust - Retail is 4.41%, while the S&P 500 yield is 1.64% [3] - The annualized dividend of $0.80 represents an 8.1% increase from the previous year [4] - Over the last 5 years, the company has increased its dividend twice year-over-year, averaging a 6.36% annual increase [4] - The current payout ratio is 59%, indicating that 59% of its trailing 12-month earnings per share (EPS) is distributed as dividends [4] Earnings Growth Expectations - For the fiscal year 2025, the Zacks Consensus Estimate predicts earnings of $1.36 per share, reflecting a year-over-year growth rate of 6.25% [5] Investment Appeal - Acadia Realty Trust is viewed as an attractive dividend investment and a compelling opportunity, holding a Zacks Rank of 2 (Buy) [7]
Devon Energy vs. Occidental: Which Energy Stock Has More Growth Ahead?
ZACKS· 2025-04-30 16:50
The oil and gas industry plays a vital role in the global economy, supplying the primary energy source for transportation, manufacturing, power generation and more. It involves the exploration, extraction, refining, transport, and sale of petroleum products. While the shift to renewables is accelerating, oil and gas remain indispensable due to their high energy density and established infrastructure. Devon Energy Corporation (DVN) and Occidental Petroleum Corporation (OXY) are major U.S. oil and gas produce ...
Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?
ZACKS· 2025-04-30 01:35
Core Insights - Pfizer (PFE) shares increased by 3% following the release of Q1 earnings that significantly exceeded expectations, although the stock has declined 10% year-to-date [1][6] - The company is trading near multi-year lows at approximately $20 per share, which may attract investors looking for a rebound [2][6] Q1 Results - Pfizer reported Q1 earnings of $0.92 per share, surpassing EPS expectations of $0.64 by 43% and up from $0.82 in the same quarter last year [3][4] - Q1 sales totaled $13.71 billion, falling short of estimates of $13.83 billion and down from $14.87 billion year-over-year [4] Full-Year Guidance - Pfizer reaffirmed its fiscal 2025 guidance, projecting revenues between $61 billion and $64 billion, with Zacks projections at $63.48 billion [7] - The company expects adjusted FY25 EPS to be in the range of $2.80 to $3.00, with the Zacks Consensus at $2.99 [7] Valuation Metrics - Pfizer's stock is trading at a price-to-forward earnings ratio of 7.7X, significantly lower than its decade-high of 20.1X and below the S&P 500's 21.3X [8] - The stock is also trading at a discount compared to the Zacks industry average of 16.4X [8] Dividend Information - Pfizer offers an annual dividend yield of 7.46%, which is substantially higher than the industry average of 2.51% and the benchmark's 1.33% [10] - The company has increased its dividend for 16 consecutive years, despite losing its dividend aristocrat status during the 2008 financial crisis [10] Market Sentiment - Following the Q1 report, Pfizer holds a Zacks Rank 2 (Buy), with earnings estimate revisions for FY25 and FY26 trending upward [12] - The company's strong performance in exceeding EPS expectations and its cost-saving initiatives may enhance its valuation and attract long-term investors [13]
Hanmi Financial (HAFC) Could Be a Great Choice
ZACKS· 2025-04-28 16:50
Company Overview - Hanmi Financial is headquartered in Los Angeles and has experienced a price change of -3.73% this year [3] - The company currently pays a dividend of $0.27 per share, resulting in a dividend yield of 4.75%, which is higher than the Banks - West industry's yield of 3.33% and the S&P 500's yield of 1.65% [3] Dividend Performance - The current annualized dividend of Hanmi Financial is $1.08, reflecting an 8% increase from the previous year [4] - Over the past five years, the company has increased its dividend three times year-over-year, with an average annual increase of 27.60% [4] - The company's payout ratio stands at 51%, indicating that it paid out 51% of its trailing 12-month earnings per share as dividends [4] Earnings Growth Expectations - For the fiscal year, Hanmi Financial anticipates solid earnings growth, with the Zacks Consensus Estimate for 2025 projected at $2.55 per share, representing a year-over-year earnings growth rate of 24.39% [5] Investment Considerations - Hanmi Financial is viewed as a compelling investment opportunity due to its attractive dividend and strong Zacks Rank of 2 (Buy) [7]
Civista Bancshares (CIVB) Could Be a Great Choice
ZACKS· 2025-04-28 16:50
Company Overview - Civista Bancshares (CIVB) is a bank holding company headquartered in Sandusky, with a price change of 0.1% so far this year [3] - The company currently pays a dividend of $0.17 per share, resulting in a dividend yield of 3.23%, which is lower than the Banks - Midwest industry's yield of 3.44% but significantly higher than the S&P 500's yield of 1.65% [3] Dividend Performance - The annualized dividend of Civista Bancshares is $0.68, reflecting a 6.3% increase from the previous year [4] - Over the last 5 years, the company has increased its dividend 4 times on a year-over-year basis, achieving an average annual increase of 9.33% [4] - The current payout ratio is 30%, indicating that the company paid out 30% of its trailing 12-month earnings per share as dividends [4] Earnings Expectations - Civista Bancshares is expected to see earnings growth this fiscal year, with the Zacks Consensus Estimate for 2025 at $2.35 per share, representing a 16.92% increase from the previous year [5] Investment Appeal - The company is viewed as an attractive dividend play and a compelling investment opportunity, holding a Zacks Rank of 2 (Buy) [7]
Why Banco Santander-Chile (BSAC) is a Top Dividend Stock for Your Portfolio
ZACKS· 2025-04-28 16:50
Company Overview - Banco Santander-Chile (BSAC) is headquartered in Santiago, Chile, and has experienced a price change of 30.01% this year [3] - The company currently pays a dividend of $1.01 per share, resulting in a dividend yield of 4.1%, which is higher than the Banks - Foreign industry's yield of 3.84% and the S&P 500's yield of 1.65% [3] Dividend Performance - The annualized dividend of $1.01 represents a 77.5% increase from the previous year [4] - Over the last five years, BSAC has increased its dividend three times year-over-year, averaging an annual increase of 9.01% [4] - The current payout ratio is 29%, indicating that the company paid out 29% of its trailing 12-month earnings per share as dividends [4] Earnings Expectations - BSAC is expected to see earnings growth this fiscal year, with the Zacks Consensus Estimate for 2025 at $2.15 per share, reflecting a 14.36% increase from the previous year [5] Investment Appeal - BSAC is considered an attractive dividend play and a compelling investment opportunity, holding a Zacks Rank of 2 (Buy) [7]
City Holding (CHCO) is a Top Dividend Stock Right Now: Should You Buy?
ZACKS· 2025-04-28 16:50
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a met ...
How To Earn $500 A Month From Honeywell International Stock Ahead Of Q1 Earnings
Benzinga· 2025-04-28 12:40
Honeywell International Inc. HON will release its first-quarter financial results before the opening bell on Tuesday, April 29. Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time. The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change. For example, if a stock pays an annual dividend of $2 and its current price is $50, its divi ...
Pfizer: I Am Locking In A 7.5% Dividend Yield Before Earnings
Seeking Alpha· 2025-04-27 10:11
Group 1 - Pfizer is expected to release its Q1 earnings soon, presenting a potential investment opportunity with a 7.55% dividend yield [1] - The dividend is considered highly likely to be safe due to Pfizer's stabilizing revenue trajectory [1] Group 2 - The article emphasizes the importance of thorough research and a long-term investment perspective in navigating market cycles [1]